Orgenesis (ORGS) Revenue & Revenue Breakdown
Orgenesis Revenue Highlights
Latest Revenue (Y)
$530.00K
Latest Revenue (Q)
$-292.00K
Orgenesis Revenue by Period
Orgenesis Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $530.00K | -98.53% |
| 2022-12-31 | $36.02M | 1.47% |
| 2021-12-31 | $35.50M | 363.96% |
| 2020-12-31 | $7.65M | -76.99% |
| 2019-12-31 | $33.26M | 78.27% |
| 2018-11-30 | $18.66M | 84.90% |
| 2017-11-30 | $10.09M | 57.71% |
| 2016-11-30 | $6.40M | 115.10% |
| 2015-11-30 | $2.97M | 100.00% |
| 2014-11-30 | - | 100.00% |
| 2013-11-30 | - | 100.00% |
| 2012-11-30 | - | 100.00% |
| 2011-11-30 | - | 100.00% |
| 2010-11-30 | - | 100.00% |
| 2009-11-30 | - | 100.00% |
| 2008-11-30 | - | - |
Orgenesis generated $530.00K in revenue during NA 2023, up -98.53% compared to the previous quarter, and up 2.84% compared to the same period a year ago.
Orgenesis Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $-292.00K | -307.09% |
| 2024-03-31 | $141.00K | -101.04% |
| 2023-12-31 | $-13.60M | -12462.73% |
| 2023-09-30 | $110.00K | -98.42% |
| 2023-06-30 | $6.97M | -0.98% |
| 2023-03-31 | $7.04M | -48.30% |
| 2022-12-31 | $13.62M | 70.56% |
| 2022-09-30 | $7.99M | 10.93% |
| 2022-06-30 | $7.20M | -0.15% |
| 2022-03-31 | $7.21M | 4.64% |
| 2021-12-31 | $6.89M | -20.56% |
| 2021-09-30 | $8.68M | -17.72% |
| 2021-06-30 | $10.54M | 12.31% |
| 2021-03-31 | $9.39M | 308.93% |
| 2020-12-31 | $2.30M | 32.79% |
| 2020-09-30 | $1.73M | -1.14% |
| 2020-06-30 | $1.75M | -6.87% |
| 2020-03-31 | $1.88M | -79.31% |
| 2019-12-31 | $9.08M | -0.48% |
| 2019-09-30 | $9.12M | 17.58% |
| 2019-06-30 | $7.76M | 6.25% |
| 2019-03-31 | $7.30M | 25.84% |
| 2018-11-30 | $5.80M | -6.87% |
| 2018-08-31 | $6.23M | 56.26% |
| 2018-05-31 | $3.99M | 51.25% |
| 2017-12-31 | $2.64M | -21.94% |
| 2017-11-30 | $3.38M | 31.81% |
| 2017-08-31 | $2.56M | 11.49% |
| 2017-05-31 | $2.30M | 24.08% |
| 2017-02-28 | $1.85M | -2.32% |
| 2016-11-30 | $1.90M | 2.54% |
| 2016-08-31 | $1.85M | 63.34% |
| 2016-05-31 | $1.13M | -25.53% |
| 2016-02-29 | $1.52M | 24.86% |
| 2015-11-30 | $1.22M | 30.03% |
| 2015-08-31 | $936.22K | 14.11% |
| 2015-05-31 | $820.42K | 100.00% |
| 2015-02-28 | - | 100.00% |
| 2014-11-30 | - | 100.00% |
| 2014-08-31 | - | 100.00% |
| 2014-05-31 | - | 100.00% |
| 2014-02-28 | - | 100.00% |
| 2013-11-30 | - | 100.00% |
| 2013-08-31 | - | 100.00% |
| 2013-05-31 | - | 100.00% |
| 2013-02-28 | - | 100.00% |
| 2012-11-30 | - | 100.00% |
| 2012-08-31 | - | 100.00% |
| 2012-05-31 | - | 100.00% |
| 2012-02-29 | - | 100.00% |
| 2011-11-30 | - | 100.00% |
| 2011-08-31 | - | 100.00% |
| 2011-05-31 | - | 100.00% |
| 2011-02-28 | - | 100.00% |
| 2010-11-30 | - | 100.00% |
| 2010-08-31 | - | 100.00% |
| 2010-05-31 | - | 100.00% |
| 2010-02-28 | - | 100.00% |
| 2009-11-30 | - | 100.00% |
| 2009-08-31 | - | 100.00% |
| 2009-05-31 | - | 100.00% |
| 2009-02-28 | - | - |
Orgenesis generated $-292.00K in revenue during Q2 2024, up -307.09% compared to the previous quarter, and up -4.15% compared to the same period a year ago.
Orgenesis Revenue Breakdown
Orgenesis Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Eliminations | $-4.42M | $-5.58M | - | - | - |
| Consolidated | - | $1.28M | - | - | - |
| POC and Hospital Services | - | - | $32.82M | $6.07M | - |
| Cell Process Development Services | - | - | $2.68M | $1.58M | - |
| Cell manufacturing services | - | - | - | - | $4.82M |
| Cell process development services | - | - | - | - | $19.93M |
| Tech transfer services | - | - | - | - | $5.40M |
| Poc Development Services | - | - | - | - | $3.11M |
Orgenesis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Eliminations (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 21 | Dec 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Nov 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Process Development Services And Hospital Services | $141.00K | - | - | - | - | - | - | - | - | - | - |
| Eliminations | - | - | $-1.87M | - | - | - | - | - | - | - | - |
| Consolidated | - | - | - | $7.04M | - | - | - | - | - | - | - |
| Cell Process Development Services | - | - | - | - | $317.00K | $519.00K | - | - | - | - | - |
| POC and Hospital Services | - | - | - | - | $6.58M | $1.78M | - | - | - | - | - |
| Cell process development services | - | - | - | - | - | - | $7.94M | $2.75M | $4.06M | $5.17M | - |
| Tech transfer services | - | - | - | - | - | - | - | $1.86M | $1.70M | $1.83M | - |
| Cell manufacturing services | - | - | - | - | - | - | - | $3.49M | $1.03M | $296.00K | - |
| Poc Services | - | - | - | - | - | - | - | $1.01M | $962.00K | - | - |
| Revenue from grants | - | - | - | - | - | - | - | - | - | - | $440.00K |
Orgenesis's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Cell Process Development Services And Hospital Services (100.00%).
Orgenesis Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 24 | Jun 23 |
|---|---|---|
| UNITED STATES | $75.00K | $2.57M |
Orgenesis's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (100.00%).
Orgenesis Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TNGX | Tango Therapeutics | $36.53M | $6.47M |
| ADAG | Adagene | $18.11M | $833.34K |
| TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
| ORGS | Orgenesis | $530.00K | $-292.00K |
| NRBO | NeuroBo Pharmaceuticals | $7.00K | - |
| DSGN | Design Therapeutics | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| LIXT | Lixte Biotechnology | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| TALS | Tourmaline Bio | - | - |
| ELYM | Eliem Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| ACHL | Achilles Therapeutics | - | - |
| INDP | Indaptus Therapeutics | - | - |
| ONCR | Oncorus | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KTTA | Pasithea Therapeutics | - | - |
ORGS Revenue FAQ
What is Orgenesis’s yearly revenue?
Orgenesis's yearly revenue for 2023 was $530K, representing a decrease of -98.53% compared to 2022. The company's yearly revenue for 2022 was $36.02M, representing an increase of 1.47% compared to 2021. ORGS's yearly revenue for 2021 was $35.5M, representing an increase of 363.96% compared to 2020.
What is Orgenesis’s quarterly revenue?
Orgenesis's quarterly revenue for Q2 2024 was $-292K, a -307.09% decrease from the previous quarter (Q1 2024), and a -104.19% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $141K, a -101.04% decrease from the previous quarter (Q4 2023), and a -98.00% decrease year-over-year (Q1 2023). ORGS's quarterly revenue for Q4 2023 was $-13.599M, a -12462.73% decrease from the previous quarter (Q3 2023), and a -199.82% decrease year-over-year (Q4 2022).
What is Orgenesis’s revenue growth rate?
Orgenesis's revenue growth rate for the last 3 years (2021-2023) was -98.51%, and for the last 5 years (2019-2023) was -98.41%.
What are Orgenesis’s revenue streams?
Orgenesis's revenue streams in c 23 are Eliminations